Sign In

mtm laboratories AG

mtm laboratories AG, founded in 1999, is a privately held biotech company based in Heidelberg, Germany. mtm specialises in the development of products for the early diagnosis and prevention of cancer.

First members of mtm’s CINtec™ product family for the early diagnosis of cervical cancer, the largest existing screening market in oncology, were already launched over the last months in Europe, Asia and the United States.Until today, mtm laboratories has raised a total of EUR 19 million.

• Show past press releases
• Edit this company

Elevator Pitch
Screening for cervical cancer still relies on subjective, morphological criteria, resulting in costs of > 6 billion p.a. for screening and follow-up in the USA alone. mtm has patent-protected the CINtec marker which is specifically overexpressed in pre-neoplastic and neoplastic cells of the cervix uteri, representing the objective parameter. mtm is developing easy-to-use and cost-efficient assays with unprecedented sensitivity and positive predictive value.

Contact Information

Im Neuenheimer Feld 583
Heidelberg D-69120
+49 (0)6221 64966 0
+49 (0)6221 64966 10
Robert J. Silverman
+1 508-366-8334

Company Facts
Founded:Dec 1999
Founders:Ruediger Ridder, PhD, Peter Pack, PhD, Magnus von Knebel Doeberitz, PhD, MD, Christina von Knebel Doeberitz, MD
CEO:Bob Silverman
CTO or technical lead:Ruediger Ridder
CFO or finance director:Martin Melcher
Head of Sales:
Head of Marketing:

Category:Biotechnology & Healthcare
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

  • Prof. Dr. Ulrich Abshagen, Chairman, Heidelberg Innovation GmbH & Co. BioScience Venture KG
  • Dr. Gerald Moeller, Vice Chairman, HBM Partners AG
  • Prof. Dr. Magnus von Knebel Doeberitz , University of Heidelberg
  • Erich Platzer, Investment Advisor, HBM Partners AG
  • Dr. Rainer Strohmenger, Partner, Wellington Partners
  • Werner Schafer

    Key Customers

  • Pathologists
  • Cytologists
  • Clinical Laboratories

    Key Business Partners

  • DakoCytomation

    Key Competitors

  • Digene
  • Molecular Diagnostics Inc.

    Capital Raised
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    No public offerings

  • Data

    Tech investments
    From our Online Data Service
    VC-backed companies
    From our Radar

    Recent Deals

    Sep 13N/AEnergy related
    Sep 13€12.6MConsumer electronics
    Sep 12€39.0MBiopharmaceuticals
    Sep 12N/AKnowledge management
    Sep 12€2.3MInternet commerce
    Sep 12€2.1MInternet services
    Sep 12€4.0MMedical devices

    For information on Europe's most extensive database on technology funding click here!


    Press Releases

    May 28
    identiq raises $5m seed, launches privacy-first identity validation...

    Apr 29
    nethone raised over $1 million from innovation nest

    Oct 1
    The Link App
    the link app launches version 2.0

    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase

    Jan 2
    Urban Jungle
    urban jungle raises 1m in seed funding to build tech-enabled home ...

    About usContact usLegal Information
    Copyright 1999-2019
    Emerging Technology Research Europe Inc. All rights reserved.